1. Home
  2. AZTR vs NCRA Comparison

AZTR vs NCRA Comparison

Compare AZTR & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.18

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

Logo Nocera Inc.

NCRA

Nocera Inc.

HOLD

Current Price

$2.31

Market Cap

3.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTR
NCRA
Founded
2014
2002
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.1M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
AZTR
NCRA
Price
$0.18
$2.31
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
1.3M
2.5M
Earning Date
05-08-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
5.06
N/A
EPS
N/A
N/A
Revenue
N/A
$13,627,944.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.06
52 Week High
$1.09
$3.98

Technical Indicators

Market Signals
Indicator
AZTR
NCRA
Relative Strength Index (RSI) 63.18 57.60
Support Level $0.15 $0.18
Resistance Level $0.23 $2.59
Average True Range (ATR) 0.01 0.26
MACD 0.01 0.00
Stochastic Oscillator 76.75 35.00

Price Performance

Historical Comparison
AZTR
NCRA

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: